About AvimerBio
A Breakthrough Protein Therapeutics Company Focused on Treatment of Inflammatory and Oncological Diseases
50M+ Americans suffer from chronic immune and inflammatory diseases, and current drug treatments are failing them.
Current drugs act by blocking cellular targets to treat infections or lower cancer risks, but they are often not curative
Larger fully human particles replicate the avidity and geometry of cell-cell signaling
Drugs that activate key sentinel immune cells have the potential to provide lasting relief
Therapeutic Applications
Proteins designed with specific valency and orientation can be optimized to present functional payloads
Targeted Drug Delivery
Protein nanoparticles act as carriers, delivering substances to cells with specificity to enhance bioactivity and minimize off-target effects
SM Discovery & Protein Imaging
Protein nanoparticles provide unique scaffolds to enable cryo-EM visualization of SM drug binding
